Project
GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for SMAD1
Z-value: 1.00
Motif logo
Transcription factors associated with SMAD1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SMAD1
|
ENSG00000170365.5 | SMAD family member 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SMAD1 | hg19_v2_chr4_+_146402925_146402957 | -0.52 | 2.0e-16 | Click! |
Activity profile of SMAD1 motif
Sorted Z-values of SMAD1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_-_106209368 | 116.24 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
| chr6_-_33048483 | 99.78 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
| chr14_-_106111127 | 78.25 |
ENST00000390545.2
|
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker) |
| chr14_-_106237742 | 67.27 |
ENST00000390551.2
|
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
| chr21_-_46330545 | 66.19 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr14_-_106092403 | 65.38 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
| chr6_+_33043703 | 62.62 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
| chr6_+_33048222 | 58.98 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
| chr16_+_222846 | 51.56 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
| chr19_+_39897453 | 48.41 |
ENST00000597629.1
ENST00000248673.3 ENST00000594045.1 ENST00000594442.1 |
ZFP36
|
ZFP36 ring finger protein |
| chr11_-_5248294 | 45.37 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
| chrX_-_107018969 | 45.03 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
| chr19_+_49838653 | 43.46 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
| chr22_+_23264766 | 42.79 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr22_+_23247030 | 42.28 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr2_+_90077680 | 42.12 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
| chr2_-_89310012 | 39.67 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr22_+_23241661 | 38.14 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr18_+_74240610 | 37.06 |
ENST00000578092.1
ENST00000578613.1 ENST00000583578.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
| chr22_+_23040274 | 36.85 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr22_+_23237555 | 35.00 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
| chr16_-_55866997 | 34.79 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
| chr6_+_31583761 | 34.67 |
ENST00000376049.4
|
AIF1
|
allograft inflammatory factor 1 |
| chrX_-_107019181 | 34.59 |
ENST00000315660.4
ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family, member 3 |
| chr2_+_90139056 | 33.54 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr22_-_19512893 | 33.29 |
ENST00000403084.1
ENST00000413119.2 |
CLDN5
|
claudin 5 |
| chr9_+_139871948 | 32.43 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr19_+_1065922 | 32.38 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr22_+_23243156 | 32.33 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
| chr17_+_38083977 | 31.28 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
| chr22_-_45559642 | 31.17 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
| chr6_+_32709119 | 30.99 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
| chr1_-_31230650 | 29.30 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
| chr9_+_139874683 | 29.24 |
ENST00000444903.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr6_+_32605195 | 29.24 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
| chr3_-_138763734 | 29.16 |
ENST00000413199.1
ENST00000502927.2 |
PRR23C
|
proline rich 23C |
| chr18_+_77439775 | 28.62 |
ENST00000299543.7
ENST00000075430.7 |
CTDP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
| chr14_-_106054659 | 28.34 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
| chr2_-_89292422 | 27.91 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr22_+_22707260 | 27.67 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
| chr6_-_31550192 | 27.53 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
| chr11_+_121461097 | 26.84 |
ENST00000527934.1
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
| chr19_-_51529849 | 26.42 |
ENST00000600362.1
ENST00000453757.3 ENST00000601671.1 |
KLK11
|
kallikrein-related peptidase 11 |
| chr19_-_54784353 | 26.13 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
| chr2_-_89399845 | 25.97 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr22_+_23134974 | 25.89 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
| chr19_-_17185848 | 25.85 |
ENST00000593360.1
|
HAUS8
|
HAUS augmin-like complex, subunit 8 |
| chr22_-_27620603 | 25.84 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
| chr17_-_29641084 | 25.74 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
| chr19_+_55141948 | 25.72 |
ENST00000396332.4
ENST00000427581.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
| chr16_+_226658 | 25.65 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
| chr4_+_76439665 | 25.15 |
ENST00000508105.1
ENST00000311638.3 ENST00000380837.3 ENST00000507556.1 ENST00000504190.1 ENST00000507885.1 ENST00000502620.1 ENST00000514480.1 |
THAP6
|
THAP domain containing 6 |
| chr16_+_66914264 | 25.13 |
ENST00000311765.2
ENST00000568869.1 ENST00000561704.1 ENST00000568398.1 ENST00000566776.1 |
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
| chr6_-_31239846 | 24.74 |
ENST00000415537.1
ENST00000376228.5 ENST00000383329.3 |
HLA-C
|
major histocompatibility complex, class I, C |
| chr9_+_139873264 | 24.64 |
ENST00000446677.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr18_-_47813940 | 24.62 |
ENST00000586837.1
ENST00000412036.2 ENST00000589940.1 |
CXXC1
|
CXXC finger protein 1 |
| chr19_+_42381173 | 24.53 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr3_-_39322728 | 24.52 |
ENST00000541347.1
ENST00000412814.1 |
CX3CR1
|
chemokine (C-X3-C motif) receptor 1 |
| chr19_-_16582815 | 23.94 |
ENST00000455140.2
ENST00000248070.6 ENST00000594975.1 |
EPS15L1
|
epidermal growth factor receptor pathway substrate 15-like 1 |
| chr22_+_23101182 | 23.68 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
| chr19_+_52901094 | 23.63 |
ENST00000391788.2
ENST00000436397.1 ENST00000391787.2 ENST00000360465.3 ENST00000494167.2 ENST00000493272.1 |
ZNF528
|
zinc finger protein 528 |
| chr22_+_23229960 | 23.51 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
| chr19_-_6690723 | 23.49 |
ENST00000601008.1
|
C3
|
complement component 3 |
| chr22_+_23165153 | 23.45 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chr4_-_1166954 | 23.30 |
ENST00000514490.1
ENST00000431380.1 ENST00000503765.1 |
SPON2
|
spondin 2, extracellular matrix protein |
| chr2_-_99224915 | 23.27 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
| chr4_+_128554081 | 23.23 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
| chr16_+_3115323 | 22.79 |
ENST00000531965.1
ENST00000396887.3 ENST00000529699.1 ENST00000526464.2 ENST00000440815.3 |
IL32
|
interleukin 32 |
| chr6_-_74161977 | 22.62 |
ENST00000370318.1
ENST00000370315.3 |
MB21D1
|
Mab-21 domain containing 1 |
| chr11_-_2323290 | 22.58 |
ENST00000381153.3
|
C11orf21
|
chromosome 11 open reading frame 21 |
| chr2_-_87017985 | 22.48 |
ENST00000352580.3
|
CD8A
|
CD8a molecule |
| chr2_+_241564655 | 22.37 |
ENST00000407714.1
|
GPR35
|
G protein-coupled receptor 35 |
| chr11_+_1891380 | 22.35 |
ENST00000429923.1
ENST00000418975.1 ENST00000406638.2 |
LSP1
|
lymphocyte-specific protein 1 |
| chr3_+_156544057 | 22.23 |
ENST00000498839.1
ENST00000470811.1 ENST00000356539.4 ENST00000483177.1 ENST00000477399.1 ENST00000491763.1 |
LEKR1
|
leucine, glutamate and lysine rich 1 |
| chr9_-_97401782 | 22.16 |
ENST00000375326.4
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr14_-_106174960 | 21.92 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
| chr22_+_23077065 | 21.88 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr2_-_89278535 | 21.84 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr1_-_204380919 | 21.75 |
ENST00000367188.4
|
PPP1R15B
|
protein phosphatase 1, regulatory subunit 15B |
| chr5_-_172198190 | 21.71 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
| chr11_+_2323349 | 21.47 |
ENST00000381121.3
|
TSPAN32
|
tetraspanin 32 |
| chr2_-_89513402 | 21.44 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr3_-_46506563 | 21.42 |
ENST00000231751.4
|
LTF
|
lactotransferrin |
| chr16_+_3115298 | 21.41 |
ENST00000325568.5
ENST00000534507.1 |
IL32
|
interleukin 32 |
| chr19_-_51875894 | 21.38 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
| chr19_+_42381337 | 21.37 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr13_-_30881621 | 21.31 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
| chr22_+_22681656 | 21.17 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr16_+_3115378 | 21.04 |
ENST00000529550.1
ENST00000551122.1 ENST00000525643.2 ENST00000548807.1 ENST00000528163.2 |
IL32
|
interleukin 32 |
| chr16_+_30483962 | 20.87 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr19_+_1067271 | 20.86 |
ENST00000536472.1
ENST00000590214.1 |
HMHA1
|
histocompatibility (minor) HA-1 |
| chr19_+_1077393 | 20.81 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chrX_+_70586140 | 20.79 |
ENST00000276072.3
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa |
| chr1_+_152635854 | 20.75 |
ENST00000368784.1
|
LCE2D
|
late cornified envelope 2D |
| chr19_+_16435625 | 20.70 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
| chr5_-_131826457 | 20.59 |
ENST00000437654.1
ENST00000245414.4 |
IRF1
|
interferon regulatory factor 1 |
| chr6_+_31582961 | 20.50 |
ENST00000376059.3
ENST00000337917.7 |
AIF1
|
allograft inflammatory factor 1 |
| chr11_+_695614 | 20.47 |
ENST00000608174.1
ENST00000397512.3 |
TMEM80
|
transmembrane protein 80 |
| chr17_-_29641104 | 20.35 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
| chr7_-_150038704 | 20.33 |
ENST00000466675.1
ENST00000482669.1 ENST00000467793.1 ENST00000223271.3 |
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2 |
| chr11_+_695787 | 20.16 |
ENST00000526170.1
ENST00000488769.1 |
TMEM80
|
transmembrane protein 80 |
| chr15_+_89181974 | 20.03 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr4_-_681114 | 19.99 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
| chr2_-_87018784 | 19.97 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
| chr2_-_11272234 | 19.76 |
ENST00000590207.1
ENST00000417697.2 ENST00000396164.1 ENST00000536743.1 ENST00000544306.1 |
AC062028.1
|
AC062028.1 |
| chr17_-_80275417 | 19.71 |
ENST00000583376.1
ENST00000578509.1 ENST00000584284.1 ENST00000582480.1 |
CD7
|
CD7 molecule |
| chr3_+_183967409 | 19.52 |
ENST00000324557.4
ENST00000402825.3 |
ECE2
|
endothelin converting enzyme 2 |
| chr3_+_45071622 | 19.45 |
ENST00000428034.1
|
CLEC3B
|
C-type lectin domain family 3, member B |
| chr4_-_1166623 | 19.42 |
ENST00000290902.5
|
SPON2
|
spondin 2, extracellular matrix protein |
| chr15_+_75074410 | 19.33 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
| chr19_-_12662240 | 19.30 |
ENST00000416136.1
ENST00000428311.1 |
ZNF564
ZNF709
|
zinc finger protein 564 ZNF709 |
| chr17_-_40021656 | 19.10 |
ENST00000319121.3
|
KLHL11
|
kelch-like family member 11 |
| chr2_-_89521942 | 19.07 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
| chr16_+_30484021 | 18.99 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr12_+_6898638 | 18.99 |
ENST00000011653.4
|
CD4
|
CD4 molecule |
| chr10_+_38299546 | 18.84 |
ENST00000374618.3
ENST00000432900.2 ENST00000458705.2 ENST00000469037.2 |
ZNF33A
|
zinc finger protein 33A |
| chr17_-_79269067 | 18.75 |
ENST00000288439.5
ENST00000374759.3 |
SLC38A10
|
solute carrier family 38, member 10 |
| chr1_+_28206150 | 18.73 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
| chr12_+_7055631 | 18.72 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
| chr17_+_34431212 | 18.70 |
ENST00000394495.1
|
CCL4
|
chemokine (C-C motif) ligand 4 |
| chr17_-_37844267 | 18.68 |
ENST00000579146.1
ENST00000378011.4 ENST00000429199.2 ENST00000300658.4 |
PGAP3
|
post-GPI attachment to proteins 3 |
| chr2_-_89340242 | 18.67 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr11_-_66360548 | 18.63 |
ENST00000333861.3
|
CCDC87
|
coiled-coil domain containing 87 |
| chr5_+_54398463 | 18.54 |
ENST00000274306.6
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
| chr19_-_6481776 | 18.46 |
ENST00000543576.1
ENST00000590173.1 ENST00000381480.2 |
DENND1C
|
DENN/MADD domain containing 1C |
| chr2_+_89923550 | 18.46 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
| chrX_-_19002696 | 18.46 |
ENST00000379942.4
|
PHKA2
|
phosphorylase kinase, alpha 2 (liver) |
| chr13_+_25338290 | 18.38 |
ENST00000255324.5
ENST00000381921.1 ENST00000255325.6 |
RNF17
|
ring finger protein 17 |
| chr3_+_153839149 | 18.32 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
| chr20_-_23066953 | 18.29 |
ENST00000246006.4
|
CD93
|
CD93 molecule |
| chr3_+_40566369 | 18.20 |
ENST00000403205.2
ENST00000310898.1 ENST00000339296.5 ENST00000431278.1 |
ZNF621
|
zinc finger protein 621 |
| chr2_-_89442621 | 18.14 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr17_+_77681075 | 18.08 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
| chr1_+_153330322 | 17.97 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
| chr7_+_100136811 | 17.96 |
ENST00000300176.4
ENST00000262935.4 |
AGFG2
|
ArfGAP with FG repeats 2 |
| chr15_+_81589254 | 17.94 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
| chr2_+_89901292 | 17.92 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr11_-_18034701 | 17.91 |
ENST00000265965.5
|
SERGEF
|
secretion regulating guanine nucleotide exchange factor |
| chr19_+_45973120 | 17.87 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr2_-_89459813 | 17.86 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr11_+_1889880 | 17.83 |
ENST00000405957.2
|
LSP1
|
lymphocyte-specific protein 1 |
| chr1_-_27961720 | 17.83 |
ENST00000545953.1
ENST00000374005.3 |
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
| chr19_-_51587502 | 17.82 |
ENST00000156499.2
ENST00000391802.1 |
KLK14
|
kallikrein-related peptidase 14 |
| chr21_-_46340770 | 17.74 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr5_-_169725231 | 17.74 |
ENST00000046794.5
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
| chr11_-_67205538 | 17.68 |
ENST00000326294.3
|
PTPRCAP
|
protein tyrosine phosphatase, receptor type, C-associated protein |
| chr1_-_161600990 | 17.56 |
ENST00000531221.1
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
| chr16_-_55867146 | 17.42 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
| chr19_-_16582754 | 17.42 |
ENST00000602151.1
ENST00000597937.1 ENST00000535753.2 |
EPS15L1
|
epidermal growth factor receptor pathway substrate 15-like 1 |
| chr14_-_107083690 | 17.31 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
| chr11_+_124492749 | 17.23 |
ENST00000531667.1
ENST00000441174.3 ENST00000375005.4 |
TBRG1
|
transforming growth factor beta regulator 1 |
| chr19_+_859425 | 17.21 |
ENST00000327726.6
|
CFD
|
complement factor D (adipsin) |
| chr19_-_36231437 | 17.18 |
ENST00000591748.1
|
IGFLR1
|
IGF-like family receptor 1 |
| chr1_-_52831796 | 17.17 |
ENST00000284376.3
ENST00000438831.1 ENST00000371586.2 |
CC2D1B
|
coiled-coil and C2 domain containing 1B |
| chr4_-_156875003 | 17.12 |
ENST00000433477.3
|
CTSO
|
cathepsin O |
| chr17_-_62009621 | 17.12 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
| chr1_+_32739733 | 17.09 |
ENST00000333070.4
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
| chr2_+_131113609 | 17.08 |
ENST00000347849.3
|
PTPN18
|
protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
| chr11_+_2421718 | 17.03 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
| chr9_+_134378289 | 16.99 |
ENST00000423007.1
ENST00000404875.2 ENST00000441334.1 ENST00000341012.7 ENST00000372228.3 ENST00000402686.3 ENST00000419118.2 ENST00000541219.1 ENST00000354713.4 ENST00000418774.1 ENST00000415075.1 ENST00000448212.1 ENST00000430619.1 |
POMT1
|
protein-O-mannosyltransferase 1 |
| chr14_-_94854926 | 16.93 |
ENST00000402629.1
ENST00000556091.1 ENST00000554720.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr21_-_46340884 | 16.87 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr14_-_106322288 | 16.82 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
| chr1_+_16767167 | 16.76 |
ENST00000337132.5
|
NECAP2
|
NECAP endocytosis associated 2 |
| chr16_-_30032610 | 16.72 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
| chr14_-_106692191 | 16.69 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
| chr6_-_159420780 | 16.67 |
ENST00000449822.1
|
RSPH3
|
radial spoke 3 homolog (Chlamydomonas) |
| chr2_-_128568721 | 16.63 |
ENST00000322313.4
ENST00000393006.1 ENST00000409658.3 ENST00000436787.1 |
WDR33
|
WD repeat domain 33 |
| chr2_+_90108504 | 16.62 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
| chr2_+_89999259 | 16.62 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr17_-_62009702 | 16.60 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
| chr2_-_89266286 | 16.59 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
| chr2_+_85921522 | 16.57 |
ENST00000409696.3
|
GNLY
|
granulysin |
| chr17_-_62084241 | 16.49 |
ENST00000449662.2
|
ICAM2
|
intercellular adhesion molecule 2 |
| chr19_-_36643329 | 16.48 |
ENST00000589154.1
|
COX7A1
|
cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
| chr19_-_36297632 | 16.46 |
ENST00000588266.2
|
PRODH2
|
proline dehydrogenase (oxidase) 2 |
| chr9_-_97402413 | 16.42 |
ENST00000414122.1
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr7_+_73623717 | 16.35 |
ENST00000344995.5
ENST00000460943.1 |
LAT2
|
linker for activation of T cells family, member 2 |
| chrX_+_70586082 | 16.32 |
ENST00000373790.4
ENST00000449580.1 ENST00000423759.1 |
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa |
| chr16_-_25122785 | 16.31 |
ENST00000563962.1
ENST00000569920.1 |
RP11-449H11.1
|
RP11-449H11.1 |
| chr5_+_157170703 | 16.30 |
ENST00000286307.5
|
LSM11
|
LSM11, U7 small nuclear RNA associated |
| chr14_-_81687197 | 16.26 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
| chr2_-_89619904 | 16.20 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
| chr11_+_2323236 | 16.19 |
ENST00000182290.4
|
TSPAN32
|
tetraspanin 32 |
| chr6_-_31324943 | 16.18 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
| chr17_-_80275466 | 16.18 |
ENST00000312648.3
|
CD7
|
CD7 molecule |
| chr17_-_71410794 | 16.17 |
ENST00000424778.1
|
SDK2
|
sidekick cell adhesion molecule 2 |
| chr6_+_29691198 | 16.11 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
| chr7_+_26438187 | 16.10 |
ENST00000439120.1
ENST00000430548.1 ENST00000421862.1 ENST00000449537.1 ENST00000420774.1 ENST00000418758.2 |
AC004540.5
|
AC004540.5 |
| chr19_+_45417921 | 16.06 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
| chr17_-_62097927 | 16.06 |
ENST00000578313.1
ENST00000584084.1 ENST00000579788.1 ENST00000579687.1 ENST00000578379.1 ENST00000578892.1 ENST00000412356.1 ENST00000418105.1 |
ICAM2
|
intercellular adhesion molecule 2 |
| chr5_-_149492904 | 16.03 |
ENST00000286301.3
ENST00000511344.1 |
CSF1R
|
colony stimulating factor 1 receptor |
| chr19_+_15752088 | 16.03 |
ENST00000585846.1
|
CYP4F3
|
cytochrome P450, family 4, subfamily F, polypeptide 3 |
| chr1_-_38157877 | 16.02 |
ENST00000477060.1
ENST00000491981.1 ENST00000488137.1 |
C1orf109
|
chromosome 1 open reading frame 109 |
| chr11_+_71927807 | 16.01 |
ENST00000298223.6
ENST00000454954.2 ENST00000541003.1 ENST00000539412.1 ENST00000536778.1 ENST00000535625.1 ENST00000321324.7 |
FOLR2
|
folate receptor 2 (fetal) |
| chr19_-_58326267 | 16.01 |
ENST00000391701.1
|
ZNF552
|
zinc finger protein 552 |
| chr17_-_41465674 | 15.97 |
ENST00000592135.1
ENST00000587874.1 ENST00000588654.1 ENST00000592094.1 |
LINC00910
|
long intergenic non-protein coding RNA 910 |
| chr19_+_50922187 | 15.95 |
ENST00000595883.1
ENST00000597855.1 ENST00000596074.1 ENST00000439922.2 ENST00000594685.1 ENST00000270632.7 |
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related) |
| chr2_-_158345462 | 15.87 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
| chr11_-_73694346 | 15.85 |
ENST00000310473.3
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
Network of associatons between targets according to the STRING database.
First level regulatory network of SMAD1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 17.0 | 68.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 16.5 | 49.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 15.9 | 47.8 | GO:1900159 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 13.7 | 54.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 13.1 | 39.4 | GO:1902955 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 13.0 | 38.9 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 12.8 | 38.3 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 12.6 | 50.3 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 12.3 | 61.7 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 12.2 | 36.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 11.8 | 94.2 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 11.1 | 44.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 10.8 | 43.4 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 10.7 | 42.9 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 10.6 | 21.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 10.6 | 95.1 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 10.3 | 51.7 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 10.2 | 724.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 10.1 | 10.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 10.0 | 30.1 | GO:0002818 | intracellular defense response(GO:0002818) |
| 9.5 | 28.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 9.4 | 9.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 9.2 | 9.2 | GO:0035878 | nail development(GO:0035878) |
| 8.8 | 26.4 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 8.5 | 51.1 | GO:1902996 | regulation of neurofibrillary tangle assembly(GO:1902996) |
| 8.5 | 17.0 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 8.5 | 25.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 8.4 | 25.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 8.3 | 41.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 8.2 | 33.0 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
| 8.1 | 24.4 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 8.1 | 24.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 7.9 | 31.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 7.7 | 7.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 7.6 | 60.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 7.6 | 45.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 7.4 | 44.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 7.3 | 43.8 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 7.2 | 43.1 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 7.2 | 21.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 7.1 | 21.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 7.1 | 141.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 7.0 | 7.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 6.9 | 20.6 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 6.8 | 6.8 | GO:0070666 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 6.6 | 616.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 6.4 | 6.4 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 6.4 | 19.1 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 6.3 | 19.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 6.3 | 50.5 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 6.3 | 31.3 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 6.0 | 18.0 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 5.9 | 5.9 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 5.8 | 17.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 5.7 | 17.1 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 5.7 | 17.1 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 5.7 | 51.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 5.6 | 5.6 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 5.6 | 22.5 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 5.6 | 5.6 | GO:0006000 | fructose metabolic process(GO:0006000) fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 5.6 | 27.8 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 5.4 | 21.7 | GO:0090677 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 5.4 | 5.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 5.4 | 21.5 | GO:0015942 | formate metabolic process(GO:0015942) |
| 5.3 | 26.5 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 5.3 | 26.4 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
| 5.2 | 10.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 5.2 | 15.6 | GO:0071529 | cementum mineralization(GO:0071529) |
| 5.2 | 5.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
| 5.1 | 10.1 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 5.0 | 15.0 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 4.9 | 24.6 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 4.9 | 29.3 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 4.9 | 14.6 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 4.8 | 4.8 | GO:0007435 | salivary gland morphogenesis(GO:0007435) |
| 4.8 | 19.3 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
| 4.8 | 86.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 4.8 | 23.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 4.7 | 47.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 4.7 | 14.1 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 4.7 | 23.4 | GO:0072144 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 4.7 | 4.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 4.6 | 64.2 | GO:0015671 | oxygen transport(GO:0015671) |
| 4.6 | 13.7 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 4.5 | 4.5 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 4.5 | 13.4 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 4.3 | 52.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 4.3 | 12.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 4.3 | 17.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 4.3 | 29.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 4.2 | 16.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 4.2 | 12.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 4.1 | 20.6 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 4.1 | 8.2 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 4.1 | 4.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 4.1 | 12.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 4.0 | 16.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 4.0 | 12.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 4.0 | 12.0 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 4.0 | 15.9 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 4.0 | 4.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 3.9 | 3.9 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 3.9 | 3.9 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 3.9 | 55.0 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 3.9 | 11.6 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 3.9 | 19.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 3.8 | 19.0 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 3.8 | 11.3 | GO:0043366 | beta selection(GO:0043366) |
| 3.7 | 11.2 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 3.7 | 22.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 3.7 | 11.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 3.7 | 18.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 3.6 | 21.9 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 3.6 | 25.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 3.6 | 25.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 3.6 | 10.7 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 3.6 | 21.3 | GO:0051013 | microtubule severing(GO:0051013) |
| 3.5 | 17.7 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 3.5 | 10.6 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 3.5 | 7.0 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 3.5 | 10.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 3.5 | 10.4 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
| 3.5 | 13.9 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 3.5 | 3.5 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
| 3.5 | 6.9 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 3.4 | 13.7 | GO:0048749 | compound eye development(GO:0048749) |
| 3.4 | 379.7 | GO:0031295 | T cell costimulation(GO:0031295) |
| 3.3 | 6.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 3.3 | 19.9 | GO:0030035 | microspike assembly(GO:0030035) |
| 3.3 | 16.6 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 3.3 | 19.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 3.3 | 3.3 | GO:0032606 | regulation of type I interferon production(GO:0032479) type I interferon production(GO:0032606) |
| 3.3 | 13.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 3.3 | 16.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 3.2 | 6.5 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 3.2 | 6.4 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
| 3.2 | 3.2 | GO:0009896 | positive regulation of catabolic process(GO:0009896) |
| 3.2 | 25.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 3.2 | 3.2 | GO:0060594 | mammary gland specification(GO:0060594) |
| 3.1 | 6.3 | GO:0002384 | hepatic immune response(GO:0002384) |
| 3.1 | 9.4 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 3.1 | 6.3 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
| 3.1 | 6.2 | GO:0070543 | response to linoleic acid(GO:0070543) |
| 3.1 | 9.3 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 3.1 | 12.4 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 3.1 | 18.6 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 3.1 | 30.9 | GO:1990403 | embryonic brain development(GO:1990403) |
| 3.1 | 9.3 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 3.1 | 6.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 3.1 | 30.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 3.1 | 9.2 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 3.0 | 9.1 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 3.0 | 18.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 3.0 | 18.2 | GO:0015811 | L-cystine transport(GO:0015811) |
| 3.0 | 15.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 3.0 | 24.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 3.0 | 9.0 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 3.0 | 9.0 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 3.0 | 12.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 3.0 | 6.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 3.0 | 23.9 | GO:0015705 | iodide transport(GO:0015705) |
| 3.0 | 23.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 3.0 | 5.9 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 3.0 | 11.8 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 2.9 | 2.9 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 2.9 | 8.8 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 2.9 | 2.9 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 2.9 | 11.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 2.9 | 14.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 2.9 | 5.8 | GO:0098780 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
| 2.9 | 8.7 | GO:0070842 | aggresome assembly(GO:0070842) |
| 2.9 | 59.9 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
| 2.8 | 28.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 2.8 | 8.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 2.8 | 11.3 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 2.8 | 11.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 2.8 | 11.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 2.8 | 19.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 2.8 | 2.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 2.8 | 8.3 | GO:0010332 | response to gamma radiation(GO:0010332) |
| 2.7 | 2.7 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 2.7 | 5.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 2.7 | 5.4 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 2.7 | 8.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 2.7 | 10.8 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 2.7 | 8.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 2.7 | 5.4 | GO:0071224 | positive regulation of immature T cell proliferation(GO:0033091) cellular response to peptidoglycan(GO:0071224) |
| 2.7 | 2.7 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 2.7 | 10.7 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 2.7 | 5.4 | GO:0002266 | follicular dendritic cell activation(GO:0002266) |
| 2.7 | 18.7 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 2.7 | 42.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 2.7 | 24.0 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
| 2.7 | 8.0 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) |
| 2.7 | 13.3 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 2.6 | 7.9 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 2.6 | 10.5 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 2.6 | 2.6 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 2.6 | 10.5 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 2.6 | 2.6 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 2.6 | 10.4 | GO:0001825 | blastocyst formation(GO:0001825) |
| 2.6 | 20.9 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 2.6 | 2.6 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 2.6 | 10.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 2.6 | 53.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 2.6 | 15.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 2.5 | 5.0 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
| 2.5 | 10.1 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 2.5 | 65.4 | GO:0002429 | immune response-activating cell surface receptor signaling pathway(GO:0002429) |
| 2.5 | 20.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 2.5 | 15.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 2.5 | 125.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 2.5 | 10.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 2.5 | 15.0 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
| 2.5 | 7.5 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
| 2.5 | 5.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 2.5 | 9.9 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 2.5 | 2.5 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
| 2.5 | 2.5 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 2.5 | 4.9 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 2.5 | 14.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 2.4 | 7.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 2.4 | 4.9 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
| 2.4 | 79.9 | GO:0006536 | glutamate metabolic process(GO:0006536) |
| 2.4 | 4.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 2.4 | 7.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 2.4 | 4.8 | GO:0002027 | regulation of heart rate(GO:0002027) |
| 2.4 | 4.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 2.4 | 23.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 2.4 | 12.0 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 2.4 | 4.8 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 2.4 | 7.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 2.4 | 19.1 | GO:0006116 | NADH oxidation(GO:0006116) |
| 2.4 | 9.5 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 2.4 | 16.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 2.4 | 7.1 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
| 2.3 | 7.0 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 2.3 | 2.3 | GO:0032571 | response to vitamin K(GO:0032571) |
| 2.3 | 2.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 2.3 | 2.3 | GO:0030317 | sperm motility(GO:0030317) |
| 2.3 | 7.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 2.3 | 9.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 2.3 | 16.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 2.3 | 6.9 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 2.3 | 6.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 2.3 | 9.2 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 2.3 | 16.0 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 2.3 | 6.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 2.3 | 6.8 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 2.3 | 9.1 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 2.3 | 9.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 2.3 | 6.8 | GO:1904529 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 2.2 | 2.2 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 2.2 | 13.4 | GO:0006477 | protein sulfation(GO:0006477) |
| 2.2 | 15.6 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 2.2 | 15.6 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 2.2 | 28.7 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
| 2.2 | 4.4 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 2.2 | 6.6 | GO:0008355 | olfactory learning(GO:0008355) |
| 2.2 | 6.6 | GO:0003218 | cardiac left ventricle formation(GO:0003218) cell migration involved in vasculogenesis(GO:0035441) |
| 2.2 | 8.8 | GO:0009450 | gamma-aminobutyric acid biosynthetic process(GO:0009449) gamma-aminobutyric acid catabolic process(GO:0009450) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 2.2 | 11.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 2.2 | 2.2 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
| 2.2 | 4.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 2.2 | 13.0 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 2.2 | 10.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 2.2 | 43.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 2.1 | 6.4 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
| 2.1 | 10.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 2.1 | 6.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 2.1 | 10.7 | GO:0050808 | synapse organization(GO:0050808) |
| 2.1 | 17.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 2.1 | 12.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 2.1 | 6.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 2.1 | 27.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 2.1 | 2.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 2.1 | 21.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 2.1 | 8.4 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
| 2.1 | 21.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 2.1 | 6.3 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 2.1 | 18.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 2.1 | 6.2 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 2.1 | 4.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 2.1 | 6.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 2.1 | 35.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 2.1 | 2.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 2.0 | 6.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 2.0 | 16.4 | GO:1903416 | response to glycoside(GO:1903416) |
| 2.0 | 12.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 2.0 | 8.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 2.0 | 6.1 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 2.0 | 12.2 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 2.0 | 14.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 2.0 | 4.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 2.0 | 16.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 2.0 | 4.0 | GO:0019233 | sensory perception of pain(GO:0019233) |
| 2.0 | 16.0 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 2.0 | 4.0 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 2.0 | 12.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 2.0 | 12.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 2.0 | 9.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 2.0 | 59.1 | GO:0045730 | respiratory burst(GO:0045730) |
| 2.0 | 19.7 | GO:0019835 | cytolysis(GO:0019835) |
| 2.0 | 9.8 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 2.0 | 5.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 2.0 | 2.0 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 1.9 | 13.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 1.9 | 5.8 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 1.9 | 7.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 1.9 | 15.4 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 1.9 | 5.8 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 1.9 | 19.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 1.9 | 246.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 1.9 | 13.4 | GO:0045007 | depurination(GO:0045007) |
| 1.9 | 1.9 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 1.9 | 20.9 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.9 | 3.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 1.9 | 13.2 | GO:0042426 | choline catabolic process(GO:0042426) |
| 1.9 | 7.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 1.9 | 7.5 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 1.9 | 26.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 1.9 | 18.5 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 1.9 | 3.7 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 1.8 | 1.8 | GO:0045726 | regulation of integrin biosynthetic process(GO:0045113) positive regulation of integrin biosynthetic process(GO:0045726) positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
| 1.8 | 5.5 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 1.8 | 11.0 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 1.8 | 1.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 1.8 | 5.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.8 | 36.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 1.8 | 1.8 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 1.8 | 5.4 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
| 1.8 | 9.0 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
| 1.8 | 18.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 1.8 | 5.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 1.8 | 3.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 1.8 | 9.0 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.8 | 7.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 1.8 | 21.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 1.8 | 3.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 1.8 | 10.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 1.8 | 7.1 | GO:0042335 | cuticle development(GO:0042335) |
| 1.7 | 28.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 1.7 | 5.2 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
| 1.7 | 6.9 | GO:0018377 | protein myristoylation(GO:0018377) |
| 1.7 | 8.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 1.7 | 12.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 1.7 | 6.8 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 1.7 | 3.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 1.7 | 5.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 1.7 | 6.7 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 1.7 | 5.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 1.7 | 6.6 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 1.7 | 9.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 1.6 | 4.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 1.6 | 9.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 1.6 | 4.9 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.6 | 21.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 1.6 | 13.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 1.6 | 9.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 1.6 | 6.5 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 1.6 | 6.5 | GO:0051608 | histamine transport(GO:0051608) |
| 1.6 | 44.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 1.6 | 1.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 1.6 | 4.9 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 1.6 | 4.9 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
| 1.6 | 9.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 1.6 | 4.8 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 1.6 | 11.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.6 | 1.6 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
| 1.6 | 9.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 1.6 | 12.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 1.6 | 3.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 1.6 | 9.4 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 1.6 | 1.6 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.6 | 4.7 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 1.6 | 6.2 | GO:1904179 | positive regulation of cardiac conduction(GO:1903781) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) positive regulation of adipose tissue development(GO:1904179) positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 1.6 | 7.8 | GO:0035799 | ureter maturation(GO:0035799) |
| 1.5 | 4.6 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 1.5 | 6.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
| 1.5 | 3.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.5 | 7.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 1.5 | 4.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 1.5 | 4.6 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 1.5 | 15.3 | GO:0015889 | cobalt ion transport(GO:0006824) cobalamin transport(GO:0015889) |
| 1.5 | 3.0 | GO:1904996 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 1.5 | 6.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 1.5 | 1.5 | GO:0070989 | oxidative demethylation(GO:0070989) |
| 1.5 | 4.5 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.5 | 30.2 | GO:0097503 | sialylation(GO:0097503) |
| 1.5 | 22.7 | GO:0035970 | p |